"Syndroms related to sudden death",,,,,,syncope,"heart failure",,"cardiac arrest",,,coma
Name,,Website,,Problems,,Genes,,,,,,
"3-hydroxy-3-methylglutaryl-CoA lyase deficiency",,https://ghr.nlm.nih.gov/condition/3-hydroxy-3-methylglutaryl-coa-lyase-deficiency#genes,,"Coma and death","An uncommon inherited disorder in which the body cannot process a particular protein building block (amino acid) called leucine. The signs and symptoms of HMG-CoA lyase deficiency usually appear within the first year of life. The condition causes episodes of vomiting, diarrhea, dehydration, extreme tiredness (lethargy), and weak muscle tone (hypotonia). During an episode, blood sugar levels can become dangerously low (hypoglycemia), and a buildup of harmful compounds can cause the blood to become too acidic (metabolic acidosis). If untreated, the disorder can lead to breathing problems, convulsions, coma, and death.","A mutation in the HMGCL gene reduces or eliminates the activity of HMG-CoA lyase, the body is unable to process leucine or make ketones properly. When leucine is not processed normally, a buildup of chemical byproducts called organic acids can result in metabolic acidosis. A shortage of ketones often leads to hypoglycemia. Metabolic acidosis and hypoglycemia can damage cells, particularly in the brain, resulting in serious illness in children with HMG-CoA lyase deficiency",,,,,,
"3-hydroxyacyl-CoA dehydrogenase deficiency",,https://ghr.nlm.nih.gov/condition/3-hydroxyacyl-coa-dehydrogenase-deficiency,,"Sudden death","Individuals with 3-hydroxyacyl-CoA dehydrogenase deficiency are also at risk for complications such as dden eath.This condition may explain some cases of sudden infant death syndrome (SIDS), which is defined as unexplained death in babies younger than 1 year.","Mutations in the HADH gene",,,,"Metabolic disease",,
"3-methylcrotonyl-CoA carboxylase deficiency",,https://ghr.nlm.nih.gov/condition/3-methylcrotonyl-coa-carboxylase-deficiency,,Coma,"3-methylcrotonyl-CoA carboxylase deficiency (also known as 3-MCC deficiency) is an inherited disorder in which the body is unable to process certain proteins properly. People with this disorder have a shortage of an enzyme that helps break down proteins containing a particular building block (amino acid) called leucine.If untreated, this disorder can lead to delayed development, seizures, and coma. ","Mutations in the MCCC1 or MCCC2 gene reduce or eliminate the activity of 3-MCC, preventing the body from processing leucine properly. As a result, toxic byproducts of leucine processing build up to harmful levels, which can damage the brain. This damage underlies the signs and symptoms of 3-MCC deficiency.",,,,,,
"Acute necrotizing encephalopathy type 1",,https://ghr.nlm.nih.gov/condition/acute-necrotizing-encephalopathy-type-1,,Coma,"A rare type of brain disease (encephalopathy) that occurs following a viral infection such as the flu.Typically appears in infancy or early childhood, although some people do not develop the condition until adolescence or adulthood. People with this condition usually show typical symptoms of an infection, such as fever, cough, congestion, vomiting, and diarrhea, for a few days. Following these flu-like symptoms, affected individuals develop neurological problems, such as seizures, hallucinations, difficulty coordinating movements (ataxia), or abnormal muscle tone. Eventually, most affected individuals go into a coma, which usually lasts for a number of weeks.Approximately one-third of individuals with acute necrotizing encephalopathy type 1 do not survive their illness and subsequent neurological decline. Of those who do survive, about half have permanent brain damage due to tissue necrosis, resulting in impairments in walking, speech, and other basic functions. Over time, many of these skills may be regained, but the loss of brain tissue is permanent. Other individuals who survive their illness appear to recover completely.","Mutations in the RANBP2 gene have been found to increase the risk of developing acute necrotizing encephalopathy type 1. ",,,,,,
"Andersen-Tawil syndrome",,https://ghr.nlm.nih.gov/condition/andersen-tawil-syndrome,,"Syncope and sudden death","A disorder that causes episodes of muscle weakness (periodic paralysis), changes in heart rhythm (arrhythmia), and developmental abnormalities. Uncommonly, the irregular heartbeats can cause fainting (syncope), and even more rarely, sudden death.","Mutations in the KCNJ2 gene cause about 60 percent of all cases of Andersen-Tawil syndrome. When the disorder is caused by mutations in this gene, it is classified as type 1 (ATS1).In the 40 percent of cases not caused by KCNJ2 gene mutations, the cause of Andersen-Tawil syndrome is usually unknown. These cases are classified as type 2 (ATS2). Studies suggest that variations in at least one other potassium channel gene may underlie the disorder in some of these affected individuals.",,,,,,
"Ankyrin-B syndrome",,https://ghr.nlm.nih.gov/condition/ankyrin-b-syndrome,,"Syncope, cardiac arrest, and Sudden death","In people with ankyrin-B syndrome, arrhythmia (heart problems related to disruption of the heart's normal rhythm) can lead to fainting (syncope) or cardiac arrest and sudden death.","mutations in the ANK2 gene",,,,"Heart disease",,
"Argininosuccinic aciduria",,https://ghr.nlm.nih.gov/condition/argininosuccinic-aciduria,,Coma,"Argininosuccinic aciduria is an inherited disorder that causes ammonia to accumulate in the blood. Argininosuccinic aciduria usually becomes evident in the first few days of life. An infant with argininosuccinic aciduria may be lacking in energy (lethargic) or unwilling to eat, and have poorly controlled breathing rate or body temperature. Some babies with this disorder experience seizures or unusual body movements, or go into a coma. ","Mutations in the ASL gene cause argininosuccinic aciduria.",,,,,,
"Aromatic l-amino acid decarboxylase deficiency",,https://ghr.nlm.nih.gov/condition/aromatic-l-amino-acid-decarboxylase-deficiency,,"Syncope and cardiac arrest","An inherited disorder that affects the way signals are passed between certain cells in the nervous system. Resulting signs and symptoms can include fainting (syncope), and cardiac arrest.","Mutations in the DDC gene result in reduced activity of the AADC enzyme. Without enough of this enzyme, nerve cells produce less dopamine and serotonin. Dopamine and serotonin are necessary for normal nervous system function, and changes in the levels of these neurotransmitters contribute to the developmental delay, intellectual disability, abnormal movements, and autonomic dysfunction seen in people with AADC deficiency.",,,,,,
"Arrhythmogenic right ventricular cardiomyopathy",,https://ghr.nlm.nih.gov/condition/arrhythmogenic-right-ventricular-cardiomyopathy,,"Sudden death, syncope, and heart failure","This condition causes part of the myocardium to break down over time, increasing the risk of an abnormal heartbeat (arrhythmia) and sudden death.ARVC may not cause any symptoms in its early stages. However, affected individuals may still be at risk of sudden death, especially during strenuous exercise.When symptoms occur, they most commonly include a sensation of fluttering or pounding in the chest (palpitations), light-headedness, and fainting (syncope). Over time, ARVC can also cause shortness of breath and abnormal swelling in the legs or abdomen. If the myocardium becomes severely damaged in the later stages of the disease, it can lead to heart failure.","ARVC can result from mutations in at least 13 genes (DSC2, DSG2, DSP, JUP, PKP2, RYR2, TGFB3, TMEM43). Many of these genes are known as desmosomal genes because they provide instructions for making components of cell structures called desmosomes. Mutations in a desmosomal gene called PKP2 appear to be most common. In people without an identified mutation, the cause of the disorder is unknown. Researchers are looking for additional genetic factors that play a role in causing ARVC.",,,,"Heart disease",,
"Beta-ketothiolase deficiency",,https://ghr.nlm.nih.gov/condition/beta-ketothiolase-deficiency,,Coma,"Beta-ketothiolase deficiency is an inherited disorder in which the body cannot effectively process a protein building block (amino acid) called isoleucine. The signs and symptoms of beta-ketothiolase deficiency typically appear between the ages of 6 months and 24 months. Affected children experience episodes of vomiting, dehydration, difficulty breathing, extreme tiredness (lethargy), and, occasionally, seizures. These episodes, which are called ketoacidotic attacks, sometimes lead to coma. ","Mutations in the ACAT1 gene reduce or eliminate the activity of the ACAT1 enzyme. A shortage of this enzyme prevents the body from processing proteins and fats properly. As a result, related compounds can build up to toxic levels in the blood. These substances cause the blood to become too acidic (ketoacidosis), which can damage the body's tissues and organs, particularly in the nervous system.",,,,,,
"Biotin-thiamine-responsive basal ganglia disease",,https://ghr.nlm.nih.gov/condition/biotin-thiamine-responsive-basal-ganglia-disease,,Coma,"Biotin-thiamine-responsive basal ganglia disease is a disorder that affects the nervous system, including a group of structures in the brain called the basal ganglia, which help control movement. As its name suggests, the condition may improve if the vitamins biotin and thiamine are given as treatment. Without early and lifelong vitamin treatment, people with biotin-thiamine-responsive basal ganglia disease experience a variety of neurological problems that gradually get worse.The signs and symptoms of biotin-thiamine-responsive basal ganglia disease usually begin between the ages of 3 and 10, but the disorder can appear at any age. Severe cases may result in coma and become life-threatening.","Mutations in the SLC19A3 gene likely result in a protein with impaired ability to transport thiamine into cells, resulting in decreased absorption of the vitamin and leading to neurological dysfunction. In this disorder, abnormalities affect several parts of the brain. Using medical imaging, generalized swelling as well as specific areas of damage (lesions) in the brain can often be seen, including in the basal ganglia. The relationship between these specific brain abnormalities and the abnormal thiamine transporter is unknown.",,,,,,
"Brugada syndrome",,https://ghr.nlm.nih.gov/condition/brugada-syndrome,,"Sudden death, syncope","If untreated, the irregular heartbeats can cause fainting (syncope), seizures, difficulty breathing, or sudden death. These complications typically occur when an affected person is resting or asleep. Signs and symptoms related to arrhythmias, including sudden death, can occur from early infancy to late adulthood. Sudden death typically occurs around age 40. This condition may explain some cases of sudden infant death syndrome (SIDS), which is a major cause of death in babies younger than 1 year. SIDS is characterized by sudden and unexplained death, usually during sleep.","Caused by mutations in one of several genes (CACNA1C, CACNA2D, CACNB2, GPD1, HCN4, KCND, KCNE, KCNE5, KCNJ, RANGR, SCN1, SCN2T, SCN3B, SCN5A, SLMAP, TRPM, TXNL4. The most commonly mutated gene in this condition is SCN5A, which is altered in approximately 30 percent of affected individuals. ",,,,"Heart disease",,
"Carbamoyl phosphate synthetase I deficiency",,https://ghr.nlm.nih.gov/condition/carbamoyl-phosphate-synthetase-i-deficiency,,Coma,"In the first few days of life, infants with carbamoyl phosphate synthetase I deficiency typically exhibit the effects of hyperammonemia, which may include  coma. ","Mutations in the CPS1 gene cause carbamoyl phosphate synthetase I deficiency. The CPS1 gene provides instructions for making the enzyme carbamoyl phosphate synthetase I, In this condition, the carbamoyl phosphate synthetase I enzyme is at low levels (deficient) or absent, and the urea cycle cannot proceed normally. As a result, nitrogen accumulates in the bloodstream in the form of toxic ammonia instead of being converted to less toxic urea and excreted. ",,,,,,
"Carbonic anhydrase VA deficiency",,https://ghr.nlm.nih.gov/condition/carbonic-anhydrase-va-deficiency,,Coma,"Characterized by episodes during which the balance of certain substances in the body is disrupted (known as metabolic crisis) and brain function is abnormal (known as acute encephalopathy). These potentially life-threatening episodes can cause coma.","Mutations in the CA5A gene result in absent or impaired carbonic anhydrase VA enzyme function, leading to reduced bicarbonate production. Insufficient bicarbonate results in impaired control of acid-base balance and reduces the activity of the four affected mitochondrial enzymes, resulting in the various biochemical abnormalities associated with carbonic anhydrase VA deficiency. These imbalances cause acute encephalopathy and the other signs and symptoms associated with this disorder. Studies suggest that a related enzyme produced from the CA5B gene may increasingly compensate for the lack of carbonic anhydrase VA as affected individuals mature, which may result in a reduced risk of metabolic crisis and acute encephalopathy after childhood.",,,,,,
"Carney complex",,https://ghr.nlm.nih.gov/condition/carney-complex,,"Sudden death","Individuals with Carney complex are at increased risk of developing noncancerous (benign) tumors called myxomas in the heart (cardiac myxoma) and other parts of the body. Cardiac myxomas may be found in any of the four chambers of the heart and can develop in more than one chamber. These tumors can block the flow of blood through the heart, causing serious complications or sudden death.","Mutations in the PRKAR1A gene cause most cases of Carney complex. ",,,,"Heart disease caused by myxomas in the heart (cardiac myxoma)",,
"Carnitine-acylcarnitine translocase deficiency",,https://ghr.nlm.nih.gov/condition/carnitine-acylcarnitine-translocase-deficiency,,"Sudden death","Many infants with CACT deficiency do not survive the newborn period. Some affected individuals have a less severe form of the condition and do not develop signs and symptoms until early childhood. These individuals are at risk for liver failure, nervous system damage, coma, and sudden death.","Mutations in the SLC25A20 gene cause CACT deficiency",,,,"Metabolic disease",,
"Carnitine palmitoyltransferase I deficiency",,https://ghr.nlm.nih.gov/condition/carnitine-palmitoyltransferase-i-deficiency,,"Sudden death","Carnitine, a natural substance acquired mostly through the diet, is used by cells to process fats and produce energy. Individuals with CPT I deficiency are at risk for nervous system damage, liver failure, seizures, coma, and sudden death. Signs and symptoms of CPT I deficiency often appear during early childhood. Affected individuals usually have low blood sugar (hypoglycemia) and a low level of ketones, which are produced during the breakdown of fats and used for energy.","Mutations in the CPT1A gene",,,,"Metabolic disease",,
"Carnitine palmitoyltransferase II deficiency",,https://ghr.nlm.nih.gov/condition/carnitine-palmitoyltransferase-ii-deficiency,,"Sudden death","Infants with the lethal neonatal form of CPT II deficiency usually live for a few days to a few months. Individuals with the severe infantile hepatocardiomuscular form of CPT II deficiency are at risk for liver failure, nervous system damage, coma, and sudden death.","Mutations in the CPT2 gene",,,,"Metabolic disease",,
"Catecholaminergic polymorphic ventricular tachycardia",,https://ghr.nlm.nih.gov/condition/catecholaminergic-polymorphic-ventricular-tachycardia,,"Sudden death, syncope","If CPVT is not recognized and treated, an episode of ventricular tachycardia may cause the heart to stop beating (cardiac arrest), leading to sudden death. Researchers suspect that CPVT may be a significant cause of sudden death in children and young adults without recognized heart abnormalities.","CPVT can result from mutations in two genes, RYR2 and CASQ2. ",,,,"Cardiac arrest ",,
"Chronic atrial and intestinal dysrhythmia",,https://ghr.nlm.nih.gov/condition/chronic-atrial-and-intestinal-dysrhythmia,,Syncope,"Symptoms related to abnormal heartbeats can include dizziness, light-headedness, fainting (syncope), ","It is unclear why SGO1 gene mutations specifically affect the heart and intestines in CAID. Researchers suggest that the activity (expression) of the SGO1 gene in certain embryonic tissues or a particular function of the SGO1 protein in the SA node and in cells that help control peristalsis may account for the features of the disorder.",,,,,,
Citrullinemia,,https://ghr.nlm.nih.gov/condition/citrullinemia,,Coma,"Type II citrullinemia chiefly affects the nervous system, causing coma. ","Mutations in the SLC25A13 gene are responsible for adult-onset type II citrullinemia, NICCD, and FTTDCD. This gene provides instructions for making a protein called citrin. Within cells, citrin helps transport molecules used in the production and breakdown of simple sugars, the production of proteins, and the urea cycle. Molecules transported by citrin are also involved in making nucleotides, which are the building blocks of DNA and its chemical cousin, RNA. Mutations in the SLC25A13 gene typically prevent cells from making any functional citrin, which inhibits the urea cycle and disrupts the production of proteins and nucleotides. The resulting buildup of ammonia and other toxic substances leads to the signs and symptoms of adult-onset type II citrullinemia. A lack of citrin also leads to the features of NICCD and FTTDCD, although ammonia does not build up in the bloodstream of individuals with these conditions.",,,,,,
"Cold-induced sweating syndrome",,https://ghr.nlm.nih.gov/condition/cold-induced-sweating-syndrome,,"Sudden death","Characterized by problems with regulating body temperature and other abnormalities affecting many parts of the body. In infancy, the features of this condition are often known as Crisponi syndrome. Researchers originally thought that cold-induced sweating syndrome and Crisponi syndrome were separate disorders, but it is now widely believed that they represent the same condition at different times during life. By six months of age, infants with Crisponi syndrome develop unexplained high fevers that increase the risk of seizures and sudden death.","About 90 percent of cases of cold-induced sweating syndrome and Crisponi syndrome result from mutations in the CRLF1 gene. These cases are designated as CISS1. The remaining 10 percent of cases are caused by mutations in the CLCF1 gene and are designated as CISS2.",,,,"Body temp regulation",,
"Combined malonic and methylmalonic aciduria",,https://ghr.nlm.nih.gov/condition/combined-malonic-and-methylmalonic-aciduria,,"The signs and symptoms of CMAMMA can begin in childhood. In some children, the buildup of acids causes the blood to become too acidic (ketoacidosis), which can damage the body's tissues and organs. Other signs and symptoms may include coma. ",,"The effects of ACSF3 gene mutations are unknown. Researchers suspect that the mutations lead to altered enzymes that have little or no function. Because the enzyme cannot convert malonic and methylmalonic acids, they build up in the body. Damage to organs and tissues caused by accumulation of these acids may be responsible for the signs and symptoms of CMAMMA, although the mechanisms are unclear.",,,,,,
"Congenital central hypoventilation syndrome",,https://ghr.nlm.nih.gov/condition/congenital-central-hypoventilation-syndrome,,SIDS,"Researchers believe that some cases of sudden infant death syndrome (SIDS) or sudden unexplained death in children may be caused by undiagnosed CCHS.","Mutations are believed to interfere with the PHOX2B protein's role in promoting neuron formation and differentiation, especially in the autonomic nervous system, resulting in the problems regulating breathing and other body functions that occur in CCHS.",,,,,,
"Congenital generalized lipodystrophy",,https://ghr.nlm.nih.gov/condition/congenital-generalized-lipodystrophy,,"Sudden death","Some affected individuals develop a form of heart disease called hypertrophic cardiomyopathy, which can lead to heart failure and an abnormal heart rhythm (arrhythmia) that can cause sudden death. Researchers have described four types of congenital generalized lipodystrophy, which are distinguished by their genetic cause. Type 4 is associated with muscle weakness, delayed development, joint abnormalities, a narrowing of the lower part of the stomach (pyloric stenosis), and severe arrhythmia that can lead to sudden death.","Mutations in the AGPAT2, BSCL2, CAV1, and CAVIN1 genes cause congenital generalized lipodystrophy types 1 through 4, respectively. ",,,,"Some affected individuals develop a form of heart disease called hypertrophic cardiomyopathy, which can lead to heart failure and an abnormal heart rhythm (arrhythmia) that can cause sudden death. Type 4 is associated with muscle weakness, delayed development, joint abnormalities, a narrowing of the lower part of the stomach (pyloric stenosis), and severe arrhythmia that can lead to sudden death.",,
"Congenital hyperinsulinism",,https://ghr.nlm.nih.gov/condition/congenital-hyperinsulinism,,Coma,"A condition that causes individuals to have abnormally high levels of insulin, which is a hormone that helps control blood sugar levels. Peopleed episodes of low blood sugar increase the risk for serious complications such as breathing difficulties, seiz ma.","Mutations in at least nine genes (ABCC8, GCK, GLUD1, HADH, HNF1A, HNF4A, KCNJ11, SLC16A1, UCP )have been found to cause congenital hyperinsulinism. Mutations in the ABCC8 gene are the most common known cause of the disorder. They account for this condition in approximately 40 percent of affected individuals. Less frequently, mutations in the KCNJ11 gene have been found in people with congenital hyperinsulinism. Mutations in each of the other genes associated with this condition account for only a small percentage of cases.",,,,,,
"Corticosterone methyloxidase deficiency",,https://ghr.nlm.nih.gov/condition/corticosterone-methyloxidase-deficiency,,Coma,"A disorder characterized by excessive amounts of sodium released in the urine (salt wasting), along with insufficient release of potassium in the urine, usually beginning in the first few weeks of life. Severe cases of corticosterone methyloxidase deficiency can result in seizures and coma and can be life-threatening. ","The CYP11B2 gene mutations that cause corticosterone methyloxidase deficiency lead to insufficient production of aldosterone, which impairs the kidneys' ability to reabsorb salt (sodium chloride or NaCl) into the blood and release potassium in the urine. As a result, excessive amounts of salt in the form of charged atoms (ions) of sodium (Na+) and chlorine (Cl-) leave the body in the urine, while not enough potassium is released. The resulting imbalance of ions in the body underlies the signs and symptoms of corticosterone methyloxidase deficiency.",,,,,,
"Critical congenital heart disease",,https://ghr.nlm.nih.gov/condition/critical-congenital-heart-disease,,"Coma and death","A group of serious heart defects that are present from birth. These abnormalities result from problems with the formation of one or more parts of the heart during the early stages of embryonic development. If untreated, CCHD can lead to shock, coma, and death. However, most people with CCHD now survive past infancy due to improvements in early detection, diagnosis, and treatment.","Studies suggest that these genes (CFC1, FOXH1, GATA4, GATA6, GDF1, GJA1, HAND1, MED13L, NKX2-5, NKX2-6, NOTCH1, SMAD6, ZFPM2. Changes in single genes have been associated with CCHD) are involved in normal heart development before birth. Most of the identified mutations reduce the amount or function of the protein that is produced from a specific gene, which likely impairs the normal formation of structures in the heart. Studies have also suggested that having more or fewer copies of particular genes compared with other people, a phenomenon known as copy number variation, may play a role in CCHD. However, it is unclear whether genes affected by copy number variation are involved in heart development and how having missing or extra copies of those genes could lead to heart defects. Researchers believe that single-gene mutations and copy number variation account for a relatively small percentage of all CCHD.",,,,,,
"Cyclic vomiting syndrome",,https://ghr.nlm.nih.gov/condition/cyclic-vomiting-syndrome,,Syncope,"A disorder that causes recurrent episodes of nausea, vomiting, and tiredness (lethargy). This condition is diagnosed most often in young children, but it can affect people of any age. Many affected people experience other symptoms during and between episodes, including fainting spells (syncope). ","The causes of cyclic vomiting syndrome have yet to be determined, researchers have proposed several factors that may contribute to the disorder. Some cases of cyclic vomiting syndrome, particularly those that begin in childhood, may be related to changes in mitochondrial DNA.",,,,,,
"Dementia with Lewy bodies",,https://ghr.nlm.nih.gov/condition/dementia-with-lewy-bodies,,Syncope,"A nervous system disorder characterized by a decline in intellectual function (dementia), a group of movement problems known as parkinsonism, visual hallucinations, sudden changes (fluctuations) in behavior and intellectual ability, and acting out dreams while asleep (REM sleep behavior disorder). This condition typically affects older adults, most often developing between ages 50 and 85. The life expectancy of individuals with dementia with Lewy bodies varies; people typically survive about 5 to 7 years after they are diagnosed. Individuals with dementia with Lewy bodies may also experience a sharp drop in blood pressure upon fainting episodes (syncope), ","Mutations in the SNCA or SNCB gene cause dementia with Lewy bodies. GBA gene mutations increase the risk of developing the condition, but are not a direct cause. ",,,,,,
"Dilated cardiomyopathy with ataxia syndrome",,https://ghr.nlm.nih.gov/condition/dilated-cardiomyopathy-with-ataxia-syndrome,,"Syncope, cardiac arrest, and Sudden death","The irregular heartbeats (arrhythmia) can lead to fainting (syncope) or cardiac arrest and sudden death. Rarely, heart problems improve over time; however, in most cases of DCMA syndrome, affected individuals do not survive past childhood due to heart failure. A small percentage of people with DCMA syndrome have no heart problems at all.","Mutations in the DNAJC19 gene ",,,,"Heart disease",,
"Early-onset myopathy with fatal cardiomyopathy",,https://ghr.nlm.nih.gov/condition/early-onset-myopathy-with-fatal-cardiomyopathy,,"Sudden death","The heart disease worsens quickly, and it often causes heart failure and sudden death in adolescence or early adulthood.Early-onset myopathy with fatal cardiomyopathy (EOMFC) is an inherited muscle disease that affects the skeletal muscles, which are used for movement, and the heart (cardiac) muscle. This condition is characterized by skeletal muscle weakness that becomes apparent in early infancy. ","EOMFC is caused by mutations in the TTN gene.",,,,"Muscle disease.  irregular heartbeat (arrhythmia), shortness of breath, extreme tiredness (fatigue), and swelling of the legs and feet. The heart abnormalities associated with EOMFC usually become apparent in childhood, after the skeletal muscle abnormalities. The heart disease worsens quickly, and it often causes heart failure and sudden death in adolescence or early adulthood.",,
"Emery-Dreifuss muscular dystrophy",,https://ghr.nlm.nih.gov/condition/emery-dreifuss-muscular-dystrophy,,"Syncope, heart failure, and sudden death","Emery-Dreifuss muscular dystrophy is a condition that primarily affects muscles used for movement (skeletal muscles) and the heart (cardiac muscle). Almost all people with Emery-Dreifuss muscular dystrophy develop heart problems by adulthood. In many cases, these heart problems are abnormalities of the electrical signals that control the heartbeat (cardiac conduction defects) and abnormal heart rhythms (arrhythmias). If untreated, these abnormalities can lead to a sensation of fluttering or pounding in the chest (palpitations), an unusually slow heartbeat (bradycardia), fainting (syncope), heart failure, and an increased risk of sudden death.If untreated, these abnormalities can lead to a sensation of fluttering or pounding in the chest (palpitations), an unusually slow heartbeat (bradycardia), fainting (syncope), heart failure, and an increased risk of sudden death.","Mutations in several genes, including EMD, FHL1, and LMNA, can cause Emery-Dreifuss muscular dystrophy. Mutations in the EMD gene or, less commonly, in the FHL1 gene cause the X-linked type of the condition. Mutations in the LMNA gene cause both the autosomal dominant and autosomal recessive types of the condition.",,,,"If untreated, these abnormalities can lead to a sensation of fluttering or pounding in the chest (palpitations), an unusually slow heartbeat (bradycardia), fainting (syncope), heart failure, and an increased risk of sudden death.",,
"Familial atrial fibrillation",,https://ghr.nlm.nih.gov/condition/familial-atrial-fibrillation,,"Syncope, sudden death","An inherited abnormality of the heart's normal rhythm. Atrial fibrillation is characterized by episodes of uncoordinated electrical activity (fibrillation) in the heart's upper chambers (the atria), which cause a fast and irregular heartbeat. If untreated, this abnormal heart rhythm (arrhythmia) can lead to dizziness, chest pain, a sensation of fluttering or pounding in the chest (palpitations), shortness of breath, or fainting (syncope). Atrial fibrillation also increases the risk of stroke and sudden death.","Familial atrial fibrillation often results from rare mutations in single genes. However, these cases represent only a small fraction of all individuals with atrial fibrillation. (ABCC9, GJA5, KCNA5, KCNE2, KCNH2, KCNJ2, KCNQ1, LMNA, MYL4, NKX2-5, NPPA, NUP155, PRKAG2, RYR2, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A)",,,,,,
"Familial dilated cardiomyopathy",,https://ghr.nlm.nih.gov/condition/familial-dilated-cardiomyopathy,,Syncope,"Familial dilated cardiomyopathy is a genetic form of heart disease. It occurs when heart (cardiac) muscle becomes thin and weakened in at least one chamber of the heart, causing the open area of the chamber to become enlarged (dilated). As a result, the heart is unable to pump blood as efficiently as usual. To compensate, the heart attempts to increase the amount of blood being pumped through the heart, leading to further thinning and weakening of the cardiac muscle. Over time, this condition results in heart failure. It usually takes many years for symptoms of familial dilated cardiomyopathy to cause health problems. They typically begin in mid-adulthood, but can occur at any time from infancy to late adulthood. Signs and symptoms of familial dilated cardiomyopathy can include an irregular heartbeat (arrhythmia), shortness of breath (dyspnea), extreme tiredness (fatigue), fainting episodes (syncope)","Mutations in more than 30 genes (ABCC9, ACTC1, ACTN2, ANKRD1, BAG3, CRYAB, CSRP3, DES, DMD, DSG2, EYA4, GATAD1, LAMA4, LDB3, LMNA, MYBPC3, MYH6, MYH7, MYPN, PLN, PSEN1, PSEN2, RBM20, SCN5A, SGCD, TAZ, TCAP, TMPO, TNNC1, TNNI3, TNNT2, TPM1, TTN, VCL)h ave been found to cause familial dilated cardiomyopathy. These genes provide instructions for making proteins that are found in cardiac muscle cells called cardiomyocytes.",,,,,,
"Familial hemiplegic migraine",,https://ghr.nlm.nih.gov/condition/familial-hemiplegic-migraine,,"Coma and death","A form of migraine headache that runs in families. Unusually severe migraine episodes have been reported in some people with familial hemiplegic migraine. These episodes have included fever, seizures, prolonged weakness, coma, and, rarely, death.","Researchers believe that mutations in the CACNA1A, ATP1A2, and SCN1A genes can upset the balance of ions in neurons, which disrupts the normal release and uptake of certain neurotransmitters in the brain. Although the mechanism is unknown, researchers speculate that mutations in the PRRT2 gene, which reduce the amount of PRRT2 protein, also disrupt normal control of neurotransmitter release. The resulting changes in signaling between neurons lead people with familial hemiplegic migraine to develop these severe headaches.",,,,,,
"Familial hemophagocytic lymphohistiocytosis",,https://ghr.nlm.nih.gov/condition/familial-hemophagocytic-lymphohistiocytosis,,Coma,"A disorder in which the immune system produces too many activated immune cells (lymphocytes) called T cells, natural killer cells, B cells, and macrophages (histiocytes). The brain may also be affected in familial hemophagocytic lymphohistiocytosis. As a result, affected individuals may experience, seizures, and coma.","Familial hemophagocytic lymphohistiocytosis may be caused by mutations in any of several genes (PRF1, STX11, STXBP2, UNC13D). These genes provide instructions for making proteins that help destroy or deactivate lymphocytes that are no longer needed. Approximately 40 to 60 percent of cases of familial hemophagocytic lymphohistiocytosis are caused by mutations in the PRF1 or UNC13D genes. Smaller numbers of cases are caused by mutations in other known genes. In some affected individuals, the genetic cause of the disorder is unknown.",,,,,,
"Glycogen storage disease type 0",,https://ghr.nlm.nih.gov/condition/glycogen-storage-disease-type-0,,"Syncope, Sudden death","The signs and symptoms of muscle GSD 0 typically begin in early childhood. Affected individuals often experience muscle pain and weakness or episodes of fainting (syncope) following moderate physical activity, such as walking up stairs. In all affected individuals, muscle GSD 0 impairs the heart's ability to effectively pump blood and increases the risk of cardiac arrest and sudden death, particularly after physical activity. Sudden death from cardiac arrest can occur in childhood or adolescence in people with muscle GSD 0.","Mutations in the GYS1 gene cause muscle GSD 0, and mutations in the GYS2 gene cause liver GSD 0. ",,,,"In all affected individuals, muscle GSD 0 impairs the heart's ability to effectively pump blood and increases the risk of cardiac arrest and sudden death, particularly after physical activity. Sudden death from cardiac arrest can occur in childhood or adolescence in people with muscle GSD 0.",,
"Gyrate atrophy of the choroid and retina",,https://ghr.nlm.nih.gov/condition/gyrate-atrophy-of-the-choroid-and-retina,,Coma,"An inherited disorder characterized by progressive vision loss. Occasionally, newborns with gyrate atrophy develop excess ammonia in the blood (hyperammonemia), which may lead to poor feeding, vomiting, seizures, or coma.","OAT gene mutations that cause gyrate atrophy result in a reduced amount of functional ornithine aminotransferase enzyme. A shortage of this enzyme impedes the conversion of ornithine into P5C. As a result, excess ornithine accumulates in the blood (hyperornithinemia), and less P5C than normal is produced. It is not clear how these changes result in the specific signs and symptoms of gyrate atrophy. ",,,,,,
"Hajdu-Cheney syndrome",,https://ghr.nlm.nih.gov/condition/hajdu-cheney-syndrome,,"Sudden death","The most serious complications of Hajdu-Cheney syndrome, which occur in about half of all affected individuals, are abnormalities known as platybasia and basilar invagination. Platybasia is a flattening of the base of the skull caused by thinning and softening of the skull bones. Basilar invagination occurs when the softened bones allow part of the spine to protrude abnormally through the opening at the bottom of the skull, pushing into the lower parts of the brain. These abnormalities can lead to severe neurological problems, including abnormal breathing, and sudden death.","Mutations in a specific area near the end of the NOTCH2 gene are associated with Hajdu-Cheney syndrome.",,,,"The most serious complications of Hajdu-Cheney syndrome, which occur in about half of all affected individuals, are abnormalities known as platybasia and basilar invagination. P",,
"Hereditary fructose intolerance",,https://ghr.nlm.nih.gov/condition/hereditary-fructose-intolerance,,"Coma and death","Continued exposure to fructose may result in seizures, coma, and ultimately death from liver and kidney failure","ALDOB gene mutations reduce the function of the enzyme, impairing its ability to metabolize fructose. A lack of functional aldolase B results in an accumulation of fructose-1-phosphate in liver cells. This buildup is toxic, resulting in the death of liver cells over time. Additionally, the breakdown products of fructose-1-phosphase are needed in the body to produce energy and to maintain blood sugar levels. The combination of decreased cellular energy, low blood sugar, and liver cell death leads to the features of hereditary fructose intolerance.",,,,,,
"Hereditary hyperekplexia",,https://ghr.nlm.nih.gov/condition/hereditary-hyperekplexia,,SIDS,"Hereditary hyperekplexia is a condition in which affected infants have increased muscle tone (hypertonia) and an exaggerated startle reaction to unexpected stimuli, especially loud noises. Following the startle reaction, infants experience a brief period in which they are very rigid and unable to move. During these rigid periods, some infants stop breathing, which, if prolonged, can be fatal. This condition may explain some cases of sudden infant death syndrome (SIDS), which is a major cause of unexplained death in babies younger than 1 year. Infants with hereditary hyperekplexia have hypertonia at all times, except when they are sleeping.","At least five genes (ARHGEF9, GLRA1, GLRB, GPHN, SLC6A5) are associated with hereditary hyperekplexia. Most of these genes provide instructions for producing proteins that are found in nerve cells (neurons). Approximately 80 percent of cases of hereditary hyperekplexia are caused by mutations in the GLRA1 gene. The GLRA1 gene provides instructions for making one part, the alpha (Î±)1 subunit, of the glycine receptor protein. GLRA1 gene mutations lead to the production of a receptor that cannot properly respond to glycine. As a result, glycine is less able to transmit signals in the spinal cord and brainstem. Mutations in the other four genes account for a small percentage of all cases of hereditary hyperekplexia.",,,,,,
"Holocarboxylase synthetase deficiency",,https://ghr.nlm.nih.gov/condition/holocarboxylase-synthetase-deficiency,,Coma,"An inherited disorder in which the body is unable to use the vitamin biotin effectively. The signs and symptoms of holocarboxylase synthetase deficiency typically appear within the first few months of life, but the age of onset varies. If left untreated, the disorder can lead to coma. These medical problems may be life-threatening in some cases.","Mutations in the HLCS gene reduce the enzyme's ability to attach biotin to these enzymes, preventing them from processing nutrients properly and disrupting many cellular functions. These defects lead to the serious medical problems associated with holocarboxylase synthetase deficiency.",,,,,,
"Isovaleric acidemia",,https://ghr.nlm.nih.gov/condition/isovaleric-acidemia,,"Coma and death","a rare disorder in which the body is unable to process certain proteins properly. ","If a mutation in the IVD gene reduces or eliminates the activity of this enzyme, the body is unable to break down leucine properly. As a result, an organic acid called isovaleric acid and related compounds build up to harmful levels in the body. This buildup damages the brain and nervous system, causing serious health problems.",,,,,,
"Jervell and Lange-Nielsen syndrome",,https://ghr.nlm.nih.gov/condition/jervell-and-lange-nielsen-syndrome,,"Syncope, Coma, Sudden death","Beginning in early childhood, the irregular heartbeats increase the risk of fainting (syncope) and sudden death. These symptoms sometimes progress to more serious medical problems, including seizures, coma, and possibly death.","About 90 percent of cases of Jervell and Lange-Nielsen syndrome are caused by mutations in the KCNQ1 gene; KCNE1 mutations are responsible for the remaining cases. ",,,,"Beginning in early childhood, the irregular heartbeats increase the risk of fainting (syncope) and sudden death.",,
"Keratoderma with woolly hair",,https://ghr.nlm.nih.gov/condition/keratoderma-with-woolly-hair,,"Sudden death","Cardiomyopathy, which is a disease of the heart muscle, is a life-threatening health problem that can develop in people with keratoderma with woolly hair. Unlike the other features of this condition, signs and symptoms of cardiomyopathy may not appear until adolescence or later. Complications of cardiomyopathy can include an abnormal heartbeat (arrhythmia), heart failure, and sudden death.","Mutations in the JUP, DSP, DSC2, and KANK2 genes cause keratoderma with woolly hair types I through IV, respectively. ",,,,"Complications of cardiomyopathy can include an abnormal heartbeat (arrhythmia), heart failure, and sudden death.",,
"Left ventricular noncompaction",,https://ghr.nlm.nih.gov/condition/left-ventricular-noncompaction,,"Sudden cardiac death, syncope","Some individuals with left ventricular noncompaction experience no symptoms at all; others have heart problems that can include sudden cardiac death. Additional signs and symptoms include irregular heart rhythm (arrhythmia), fainting (syncope),","Mutations in several genes (ACTC1, DTNA, HCN4, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, SCN5A, TAZ, TNNT2, TPM )have been found to cause left ventricular noncompaction. Mutations in the MYH7 and MYBPC3 genes have been estimated to cause up to 30 percent of cases; mutations in other genes are each responsible for a small percentage of cases. However, the cause of the condition is often unknown.",,,,,,
"Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency",,https://ghr.nlm.nih.gov/condition/long-chain-3-hydroxyacyl-coa-dehydrogenase-deficiency#genes,,"Sudden death","Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a rare condition that prevents the body from converting certain fats to energy, particularly during periods without food (fasting). Individuals with LCHAD deficiency are also at risk for serious heart problems, breathing difficulties, coma, and sudden death.","Mutations in the HADHA gene ",,,,"Individuals with LCHAD deficiency are also at risk for serious heart problems, breathing difficulties, coma, and sudden death.",,
"Lysinuric protein intolerance",,https://ghr.nlm.nih.gov/condition/lysinuric-protein-intolerance,,Coma,"a disorder caused by the body's inability to digest and use certain protein building blocks (amino acids), namely lysine, arginine, and ornithine. A lack of certain amino acids can cause elevated levels of ammonia in the blood. If ammonia levels are too high for too long, they can cause coma","Mutations in the SLC7A7 gene cause lysinuric protein intolerance.",,,,,,
"Maple syrup urine disease",,https://ghr.nlm.nih.gov/condition/maple-syrup-urine-disease,,"Coma and death","An inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. The condition gets its name from the distinctive sweet odor of affected infants' urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death.","Mutations in any of these three genes (BCKDHA, BCKDHB, DBT) reduce or eliminate the function of the protein complex, preventing the normal breakdown of leucine, isoleucine, and valine. As a result, these amino acids and their byproducts build up in the body. Because high levels of these substances are toxic to the brain and other organs, their accumulation leads to the serious health problems associated with maple syrup urine disease. Researchers are studying other genes, PPM1K,  related to the same protein complex that may also be associated with maple syrup urine disease.",,,,,,
"Medium-chain acyl-CoA dehydrogenase deficiency",,https://ghr.nlm.nih.gov/condition/medium-chain-acyl-coa-dehydrogenase-deficiency,,"Coma and death","A condition that prevents the body from converting certain fats to energy, particularly during periods without food (fasting). Signs and symptoms of MCAD deficiency typically appear during infancy or early childhood. In rare cases, symptoms of this disorder are not recognized early in life, and the condition is not diagnosed until adulthood. People with MCAD deficiency are at risk of serious complications such as coma, and sudden death.","Mutations in the ACADM gene lead to a shortage (deficiency) of the MCAD enzyme within cells. Without sufficient amounts of this enzyme, medium-chain fatty acids are not metabolized properly. As a result, these fats are not converted to energy, which can lead to the characteristic signs and symptoms of this disorder such as lethargy and hypoglycemia.",,,,,,
"Megalencephalic leukoencephalopathy with subcortical cysts",,https://ghr.nlm.nih.gov/condition/megalencephalic-leukoencephalopathy-with-subcortical-cysts,,Coma,"A progressive condition that affects brain development and function. Individuals with this condition typically have an enlarged brain (megalencephaly) that is evident at birth or within the first year of life. Minor head trauma can further impair movements and may lead to coma.","Mutations in the MLC1 gene cause megalencephalic leukoencephalopathy with subcortical cysts type 1; this type accounts for 75 percent of all cases. It is unknown how a lack of functional MLC1 or GlialCAM protein at cell junctions in the brain impairs brain development and function, causing the signs and symptoms of megalencephalic leukoencephalopathy with subcortical cysts. Mutations in the HEPACAM gene cause megalencephalic leukoencephalopathy with subcortical cysts types 2A and 2B; together, these types account for 20 percent of all cases. Approximately 5 percent of people with megalencephalic leukoencephalopathy with subcortical cysts do not have identified mutations in the MLC1 or HEPACAM gene. ",,,,,,
"Methylmalonic acidemia",,https://ghr.nlm.nih.gov/condition/methylmalonic-acidemia,,"Coma and death","An inherited disorder in which the body is unable to process certain proteins and fats (lipids) properly. Without treatment, this disorder can lead to coma and death in some cases.","Mutations in the MUT, MMAA, MMAB, MMADHC, and MCEE genes cause methylmalonic acidemia. The long term effects of methylmalonic acidemia depend on which gene is mutated and the severity of the mutation. About 60 percent of methylmalonic acidemia cases are caused by mutations in the MUT gene. It is likely that mutations in other, unidentified genes also cause methylmalonic acidemia.",,,,,,
"Mitochondrial trifunctional protein deficiency",,https://ghr.nlm.nih.gov/condition/mitochondrial-trifunctional-protein-deficiency,,"Sudden death AND coma","Infants with this disorder are also at high risk for serious heart problems, breathing difficulties, coma, and sudden death. ","Mutations in the HADHA and HADHB genes cause mitochondrial trifunctional protein deficiency. ",,,,"Infants with this disorder are also at high risk for serious heart problems, breathing difficulties, coma, and sudden death.",,
"N-acetylglutamate synthase deficiency",,https://ghr.nlm.nih.gov/condition/n-acetylglutamate-synthase-deficiency,,Coma,"An inherited disorder that causes ammonia to accumulate in the blood. May become evident in the first few days of life. Some babies with this disorder may experience seizures or unusual body movements, or go into a coma. In some affected individuals, signs and symptoms of N-acetylglutamate synthase deficiency are less severe, and do not appear until later in life. Some people with this form of the disorder cannot tolerate high-protein foods such as meat. They may experience sudden episodes of ammonia toxicity, resulting in coma, in response to illness or other stress.","Mutations in the NAGS gene cause N-acetylglutamate synthase deficiency.",,,,,,
"Neurohypophyseal diabetes insipidus",,https://ghr.nlm.nih.gov/condition/neurohypophyseal-diabetes-insipidus,,Coma,"People with neurohypophyseal diabetes insipidus can quickly become dehydrated if they do not drink enough water. Dehydration can lead to constipation and dry skin. If the disorder is not treated, more serious complications of dehydration can occur. These include coma.","Mutations in the AVP gene result in progressive damage to the brain cells where ADH is produced. These cells ultimately die, causing a shortage of ADH. Without this hormone, the kidneys do not reabsorb water as they should, and the body makes excessive amounts of urine. ",,,,,,
"Ornithine transcarbamylase deficiency",,https://ghr.nlm.nih.gov/condition/ornithine-transcarbamylase-deficiency,,Coma,"An inherited disorder that causes ammonia to accumulate in the blood.An infant with the neonatal-onset form of ornithine transcarbamylase deficiency may be lacking in energy (lethargic) or unwilling to eat, and have a poorly-controlled breathing rate or body temperature. Infants with this disorder may be described as ""floppy"" and can experience seizures or coma. ","Mutations in the OTC gene cause ornithine transcarbamylase deficiency",,,,,,
"Ornithine translocase deficiency",,https://ghr.nlm.nih.gov/condition/ornithine-translocase-deficiency,,Coma,"Ornithine translocase deficiency varies widely in its severity and age of onset. An infant with ornithine translocase deficiency may be lacking in energy (lethargic) or refuse to eat, or have poorly controlled breathing or body temperature. Some babies with this disorder may experience seizures or unusual body movements, or go into a coma. ","Mutations in the SLC25A15 gene result in a mitochondrial ornithine transporter that is unstable or the wrong shape, and which cannot bring ornithine to the mitochondrial matrix. This failure of ornithine transport causes an interruption of the urea cycle and the accumulation of ammonia, ",,,,,,
Preeclampsia,,https://ghr.nlm.nih.gov/condition/preeclampsia,,Coma,"A complication of pregnancy in which affected women develop high blood pressure (hypertension); they can also have abnormally high levels of protein in their urine (proteinuria). This condition usually occurs in the last few months of pregnancy and often requires early delivery of the infant.In many cases, symptoms of preeclampsia go away within a few days after the baby is born. In severe cases, however, preeclampsia can damage the mother's organs, such as the heart, liver, and kidneys, and can lead to life-threatening complications. Extremely high blood pressure in the mother can cause bleeding in the brain (hemorrhagic stroke). The effects of high blood pressure on the brain (hypertensive encephalopathy) may also result in seizures. If seizures occur, the condition is considered to have worsened to eclampsia, which can result in coma. ","The specific causes of preeclampsia are not well understood. In pregnancy, blood volume normally increases to support the fetus, and the mother's body must adjust to handle this extra fluid. In some women the body does not react normally to the fluid changes of pregnancy, leading to the signs and symptoms of preeclampsia.",,,,,,
"Primary carnitine deficiency",,https://ghr.nlm.nih.gov/condition/primary-carnitine-deficiency,,"Sudden death AND coma","Primary carnitine deficiency is a condition that prevents the body from using certain fats for energy, particularly during periods without food (fasting). Carnitine, a natural substance acquired mostly through the diet, is used by cells to process fats and produce energy.All individuals with this disorder are at risk for heart failure, liver problems, coma, and sudden death.","Mutations in the SLC22A5 gene cause primary carnitine deficiency.",,,,"All individuals with this disorder are at risk for heart failure, liver problems, coma, and sudden death.",,
"Progressive familial heart block",,https://ghr.nlm.nih.gov/condition/progressive-familial-heart-block,,"Syncope, sudden cardiac arrest, and death","Complete heart block can cause fainting (syncope), or sudden cardiac arrest and death.","Mutations in the SCN5A and TRPM4 genes cause most cases of progressive familial heart block types IA and IB, respectively. The SCN5A and TRPM4 gene mutations that cause progressive familial heart block alter the normal function of the channels. As a result of these channel alterations, cardiac cells have difficulty producing and transmitting the electrical signals that are necessary to coordinate normal heartbeats, leading to heart block. Death of these impaired cardiac cells over time can lead to fibrosis, worsening the heart block.Mutations in other genes (GJA5, SCN1B), some of which are unknown, account for the remaining cases of progressive familial heart block.",,,,,,
"Propionic acidemia",,https://ghr.nlm.nih.gov/condition/propionic-acidemia,,"Coma and death","An inherited disorder in which the body is unable to process certain parts of proteins and lipids (fats) properly. It is classified as an organic acid disorder, which is a condition that leads to an abnormal buildup of particular acids known as organic acids. In most cases, the features of propionic acidemia become apparent within a few days after birth. The initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These symptoms sometimes progress to more serious medical problems, including heart abnormalities, seizures, coma, and possibly death","Mutations in the PCCA or PCCB gene disrupt the function of the enzyme and prevent the normal breakdown of these molecules. As a result, a substance called propionyl-CoA and other potentially harmful compounds can build up to toxic levels in the body. This buildup damages the brain and nervous system, causing the serious health problems associated with propionic acidemia.",,,,,,
"Pyruvate carboxylase deficiency",,https://ghr.nlm.nih.gov/condition/pyruvate-carboxylase-deficiency,,"Coma and death","Pyruvate carboxylase deficiency type B has life-threatening signs and symptoms that become apparent shortly after birth. This form of the condition has been reported mostly in Europe, particularly France. Affected infants have severe lactic acidosis, a buildup of ammonia in the blood (hyperammonemia), and liver failure. They experience neurological problems including weak muscle tone (hypotonia), abnormal movements, seizures, and coma. Infants with this form of the condition usually survive for less than 3 months after birth.","Mutations in the PC gene reduce the amount of pyruvate carboxylase in cells or disrupt the enzyme's activity. The missing or altered enzyme cannot carry out its essential role in generating glucose, which impairs the body's ability to make energy in mitochondria. Additionally, a loss of pyruvate carboxylase allows compounds such as lactic acid and ammonia to build up and damage organs and tissues. Researchers suggest that the loss of pyruvate carboxylase function in the nervous system, particularly the role of the enzyme in myelin formation and neurotransmitter production, also contributes to the neurologic features of pyruvate carboxylase deficiency.",,,,,,
"Romano-Ward syndrome",,https://ghr.nlm.nih.gov/condition/romano-ward-syndrome,,"Syncope, Cardiac arrest, Sudden death","A condition that causes a disruption of the heart's normal rhythm (arrhythmia). The arrhythmia associated with Romano-Ward syndrome can lead to fainting (syncope) or cardiac arrest and sudden death. However, some people with Romano-Ward syndrome never experience any health problems associated with the condition.","Mutations in the KCNQ1, KCNH2, and SCN5A genes are the most common causes of Romano-Ward syndrome. Mutations in other genes (AKAP, CALM, CALM, CAV3, KCNJ, SCN4n, and SNTA1 involved in ion transport can also cause Romano-Ward syndrome; each of these additional genes is associated with a very small percentage of cases.",,,,"The arrhythmia associated with Romano-Ward syndrome can lead to fainting (syncope) or cardiac arrest and sudden death. However, some people with Romano-Ward syndrome never experience any health problems associated with the condition.",,
"Short/branched chain acyl-CoA dehydrogenase deficiency",,https://ghr.nlm.nih.gov/condition/short-branched-chain-acyl-coa-dehydrogenase-deficiency,,Coma,"A small percentage of affected individuals develop signs and symptoms of the condition, which can begin soon after birth or later in childhood. The initial symptoms often include poor feeding, lack of energy (lethargy), vomiting, and irritability. These symptoms sometimes progress to serious health problems such as difficulty breathing, seizures, and coma","Mutations in the ACADSB gene reduce or eliminate the activity of this enzyme. With a shortage (deficiency) of SBCAD activity, the body is unable to break down isoleucine properly. Researchers speculate that some features of this disorder, such as lethargy and muscle weakness, occur because isoleucine is not converted to energy. In addition, impairment of SBCAD may allow the buildup of toxic compounds, which can lead to serious health problems.",,,,,,
"Short QT syndrome",,https://ghr.nlm.nih.gov/condition/short-qt-syndrome,,"Syncope, Cardiac arrest, sudden death, SIDS","Short QT syndrome is a condition that can cause a disruption of the heart's normal rhythm (arrhythmia). If untreated, the arrhythmia associated with short QT syndrome can lead to a variety of signs and symptoms, from dizziness and fainting (syncope) to cardiac arrest and sudden death. These signs and symptoms can occur any time from early infancy to old age. This condition may explain some cases of sudden infant death syndrome (SIDS), which is a major cause of unexplained death in babies younger than 1 year. However, some people with short QT syndrome never experience any health problems associated with the condition.","Mutations in the KCNH2, KCNJ2, and KCNQ1 genes can cause short QT syndrome. Some affected individuals do not have an identified mutation in the KCNH2, KCNJ2, or KCNQ1 gene. Changes in other genes that have not been identified may cause the disorder in these cases.",,,,"If untreated, the arrhythmia associated with short QT syndrome can lead to a variety of signs and symptoms, from dizziness and fainting (syncope) to cardiac arrest and sudden death. These signs and symptoms can occur any time from early infancy to old age.",,
"Sick sinus syndrome",,https://ghr.nlm.nih.gov/condition/sick-sinus-syndrome,,"Syncope, heart failure, cardiac arrest","Symptoms related to abnormal heartbeats can include dizziness, light-headedness, fainting (syncope). Sick sinus syndrome occurs most commonly in older adults, although it can be diagnosed in people of any age. The condition increases the risk of several life-threatening problems involving the heart and blood vessels. These include a heart rhythm abnormality called heart failure, cardiac arrest, and stroke.","Genetic changes are an uncommon cause of sick sinus syndrome. Mutations in two genes, SCN5A and HCN4, have been found to cause the condition in a small number of families. A particular variation in another gene, MYH6, appears to increase the risk of developing sick sinus syndrome.",,,,,,
Sitosterolemia,,https://ghr.nlm.nih.gov/condition/sitosterolemia,,"Sudden death","Sitosterolemia is a condition in which fatty substances (lipids) from vegetable oils, nuts, and other plant-based foods accumulate in the blood and tissues. These lipids are called plant sterols (or phytosterols). Sitosterol is one of several plant sterols that accumulate in this disorder, with a blood level 30 to 100 times greater than normal. In people with sitosterolemia, accumulation of fatty deposits in arteries (atherosclerosis) can occur as early as childhood. These deposits narrow the arteries and can eventually block blood flow, increasing the chance of a heart attack, stroke, or sudden death.","Sitosterolemia is caused by mutations in the ABCG5 or ABCG8 gene. ",,,,"In people with sitosterolemia, accumulation of fatty deposits in arteries (atherosclerosis) can occur as early as childhood. These deposits narrow the arteries and can eventually block blood flow, increasing the chance of a heart attack, stroke, or sudden death.",,
"Sporadic hemiplegic migraine",,https://ghr.nlm.nih.gov/condition/sporadic-hemiplegic-migraine,,Coma,"Some people with sporadic hemiplegic migraine experience unusually severe migraine episodes. These episodes can include fever, prolonged weakness, seizures, and coma. ","Mutations in the ATP1A2 and CACNA1A genes disrupt the transport of ions in neurons, which is thought to impair the normal release and uptake of certain neurotransmitters in the brain. The resulting abnormal signaling may lead to the severe headaches and auras characteristic of sporadic hemiplegic migraine.",,,,,,
"Succinyl-CoA:3-ketoacid CoA transferase deficiency",,https://ghr.nlm.nih.gov/condition/succinyl-coa3-ketoacid-coa-transferase-deficiency,,Coma,"The signs and symptoms of SCOT deficiency typically appear within the first few years of life. Affected individuals experience episodes of extreme tiredness (lethargy), appetite loss, vomiting, rapid breathing, and, occasionally, seizures. These episodes, which are called ketoacidotic attacks, sometimes lead to coma. About half of affected individuals have a ketoacidotic attack within the first 4 days of life. Affected individuals have no symptoms of the disorder between ketoacidotic attacks.","OXCT1 gene mutations result in the production of a SCOT enzyme with little or no function. A reduction in the amount of functional enzyme leads to an inability to break down ketones, resulting in decreased energy production and an elevated level of ketones in the blood. If these signs become severe, a ketoacidotic attack can occur. Individuals with mutations that create an enzyme with partial function are still prone to ketoacidotic attacks, but are less likely to have persistent ketosis.",,,,,,
"Timothy syndrome",,https://ghr.nlm.nih.gov/condition/timothy-syndrome,,"Sudden death","Timothy syndrome is characterized by a heart condition called long QT syndrome, which causes the heart (cardiac) muscle to take longer than usual to recharge between beats. This abnormality in the heart's electrical system can cause irregular heartbeats (arrhythmia), which can lead to sudden death. Researchers have identified two forms of Timothy syndrome. Type 2, or the atypical type, causes a more severe form of long QT syndrome and a greater risk of arrhythmia and sudden death.","Mutations in the CACNA1C gene",,,,"Abnormality in the heart's electrical system can cause irregular heartbeats (arrhythmia), which can lead to sudden death.",,
"Type 1 diabetes",,https://ghr.nlm.nih.gov/condition/type-1-diabetes,,"Coma and death","In severe cases, diabetic ketoacidosis can lead to coma and death.","Type 1 diabetes is generally considered to be an autoimmune disorder. Autoimmune disorders occur when the immune system attacks the body's own tissues and organs. For unknown reasons, in people with type 1 diabetes the immune system damages the insulin-producing beta cells in the pancreas. Damage to these cells impairs insulin production and leads to the signs and symptoms of type 1 diabetes.The risk of developing type 1 diabetes is increased by certain variants of the HLA-DQA1, HLA-DQB1, and HLA-DRB1 genes. These genes provide instructions for making proteins that play a critical role in the immune system. The HLA-DQA1, HLA-DQB1, and HLA-DRB1 genes belong to a family of genes called the human leukocyte antigen (HLA) complex. The HLA complex helps the immune system distinguish the body's own proteins from proteins made by foreign invaders such as viruses and bacteria. Also other identified (CCR5, CTLA4, FOXP3, HLA-DQA1, HLA-DQB1, HLA-DRB1, HNF1A, IL2RA, IL6, INS, ITPR3, OAS1, PTPN22, SUMO)",,,,,,
"Wolff-Parkinson-White syndrome",,https://ghr.nlm.nih.gov/condition/wolff-parkinson-white-syndrome,,"Syncope, Cardiac arrest, Sudden death","Resulting symptoms include dizziness, a sensation of fluttering or pounding in the chest (palpitations), shortness of breath, and fainting (syncope). In rare cases, arrhythmias associated with Wolff-Parkinson-White syndrome can lead to cardiac arrest and sudden death. ","In most cases, the cause of Wolff-Parkinson-White syndrome is unknown. A small percentage of all cases are caused by mutations in the PRKAG2 gene.",,,,"In rare cases, arrhythmias associated with Wolff-Parkinson-White syndrome can lead to cardiac arrest and sudden death. ",,
"X-linked adrenoleukodystrophy",,https://ghr.nlm.nih.gov/condition/x-linked-adrenoleukodystrophy,,Coma,"X-linked adrenoleukodystrophy is a genetic disorder that occurs primarily in males. It mainly affects the nervous system and the adrenal glands, which are small glands located on top of each kidney. In this disorder, the fatty covering (myelin) that insulates nerves in the brain and spinal cord is prone to deterioration (demyelination), which reduces the ability of the nerves to relay information to the brain. In addition, damage to the outer layer of the adrenal glands (adrenal cortex) causes a shortage of certain hormones (adrenocortical insufficiency). Adrenocortical insufficiency may cause weakness, weight loss, skin changes, vomiting, and coma.","ABCD1 gene mutations result in a shortage (deficiency) of ALDP. When this protein is lacking, the transport and subsequent breakdown of VLCFAs is disrupted, causing abnormally high levels of these fats in the body. The accumulation of VLCFAs may be toxic to the adrenal cortex and myelin. Research suggests that the accumulation of VLCFAs triggers an inflammatory response in the brain, which could lead to the breakdown of myelin. ",,,,,,
"X-linked cardiac valvular dysplasia",,https://ghr.nlm.nih.gov/condition/x-linked-cardiac-valvular-dysplasia,,"Sudden death","X-linked cardiac valvular dysplasia is a condition characterized by the abnormal development (dysplasia) of heart (cardiac) valves. Other rare complications of X-linked cardiac valvular dysplasia include inflammation of the inner lining of the heart (endocarditis), abnormal blood clots, or sudden death.","Caused by mutations in the FLNA gene",,,,"Other rare complications of X-linked cardiac valvular dysplasia include inflammation of the inner lining of the heart (endocarditis), abnormal blood clots, or sudden death.",,
